This inventor holds 4 USPTO granted patents. Top assignees: Boston University, The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of. Active years: 1991-1996.
Company Filing History:
2 out of 832 
1 out of 1,217 
1 out of 2,202 
Years Active: 1991-1996
Title: James L Cornette: Innovator in Molecular Modeling and Drug Design
Introduction
James L Cornette is a notable inventor based in Ames, IA (US), recognized for his contributions to molecular modeling and drug design. With a total of 4 patents, Cornette has made significant strides in the field of computational biology.
Latest Patents
Cornette's latest patents include a "Molecular modeling method and system," which provides a computer-based approach for generating both two- and three-dimensional representations of molecules. This method involves establishing coordinate axes and a grid of coordinates to identify atom and solvent points, ultimately allowing for the creation of three-dimensional models. Another significant patent is the "General strategy for vaccine and drug design," which focuses on computing the conformation and location of protein fragments in binding to receptor active sites. This invention aids in the design of both natural and artificial ligands with beneficial binding characteristics.
Career Highlights
Throughout his career, Cornette has worked with prestigious institutions, including Boston University and the United States Department of Health. His work has contributed to advancements in the understanding of molecular interactions and drug development.
Collaborations
Cornette has collaborated with notable figures in the field, including Charles DeLisi and Jay A Berzofsky. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
James L Cornette's work in molecular modeling and drug design exemplifies the importance of innovation in the scientific community. His patents and collaborations continue to influence the development of new therapeutic strategies.